Esperion Therapeutics, Inc. (LON:0IIM)

Esperion Therapeutics Revenue

Esperion Therapeutics had revenue of $65.00M USD in the quarter ending March 31, 2025, a decrease of -52.81%. This brings the company's revenue in the last twelve months to $259.57M, up 12.99% year-over-year. In the year 2024, Esperion Therapeutics had annual revenue of $332.31M with 185.66% growth.

• Revenue (ttm): $259.57M
• Revenue Growth: +12.99%
• P/S Ratio: 0.72
• Revenue / Employee: $853.86K
• Employees: 304
• Market Cap: 144.58M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	332.31M	215.98M	185.66%
Dec 31, 2023	116.33M	40.86M	54.14%
Dec 31, 2022	75.48M	-2.97M	-3.79%
Dec 31, 2021	78.45M	-149.10M	-65.52%
Dec 31, 2020	227.55M	79.18M	53.37%